![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t1.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b00ec3b5c948edf23aee4a53715047a99d635529/2-Table2-1.png)
Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
![Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram](https://www.researchgate.net/publication/51364152/figure/fig1/AS:601578260164637@1520438842613/Relationship-between-CA-15-3-serum-levels-and-size-of-the-tumor-in-the-overall-population.png)
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-1.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram](https://www.researchgate.net/publication/329615156/figure/fig2/AS:703368083275776@1544707427023/serum-Ca-15-3-behavior-during-postoperative-follow-up-of-patient-2-Abbreviations-Bs.png)
serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram
![Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4244574818b6181db84800ea19173a80fa71094b/2-TableII-1.png)
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar
![Table 1 from Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes. | Semantic Scholar Table 1 from Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/85beba502134efe48f36f8bb81821a821a174fd7/2-Table1-1.png)